The UK government website has announced that the Office for Health Improvement and Disparities has released an updated quit smoking guide for doctors, highlighting the harm reduction and potential for quitting smoking with the aid of e-cigarettes in the section on smoking cessation aids.
It has been reported that currently 52.7% of smokers in the UK want to quit, but relying solely on willpower results in a low success rate. Therefore, professional guidance from doctors is crucial in assisting smokers to effectively use quitting aids and significantly improve their chances of success.
It is worth mentioning that this guideline highlights the harm reduction and smoking cessation potential of e-cigarettes in the section on smoking cessation assistance, particularly emphasizing the importance of informing doctors about them. The hope is that doctors can better understand e-cigarettes.
There is mounting evidence that shows the significant effectiveness of e-cigarettes as a tool for quitting smoking. A comprehensive review of studies conducted by the Cochrane Collaboration, an international organization of evidence-based medical professionals, in 2021 shows that e-cigarettes have a quit-smoking effect, with a success rate twice that of nicotine replacement therapy and nicotine-free e-cigarettes.
Source: Southern News Net.
Disclaimer
This article is provided solely for professional research, industry discussion, and informational purposes. Any references to brands, companies, products, technologies, or policies are made for factual reporting and analytical purposes only, and do not constitute endorsement, recommendation, promotion, or advertising by 2Firsts.
Nicotine-containing products, including but not limited to cigarettes, e-cigarettes, heated tobacco products, and nicotine pouches, carry significant health risks. Readers are responsible for complying with all applicable laws and regulations in their respective jurisdictions, including age restrictions and access limitations.
The information contained in this article should not be regarded as investment, legal, medical, regulatory, or commercial advice. While 2Firsts strives to ensure the accuracy and reliability of its content, it does not assume liability for any direct or indirect loss arising from errors, omissions, inaccuracies, or reliance on the information contained herein.
This article is not intended for individuals below the legal age for accessing tobacco or nicotine-related information in their jurisdiction.
Copyright Notice
This article is either original content produced by 2Firsts or content reproduced, translated, summarized, or adapted from third-party sources with attribution where applicable. The intellectual property rights of the original content remain with 2Firsts or the respective original rights holders.
No individual or organization may copy, reproduce, distribute, republish, modify, translate, or otherwise use this content without prior authorization. Any unauthorized use may result in legal action.
For copyright-related inquiries, corrections, or removal requests, please contact: info@2firsts.com.
AI-Assisted Translation and Editing Notice
Portions of this article may have been translated, edited, or reviewed with the assistance of artificial intelligence tools to improve efficiency and readability. Due to the limitations of AI-assisted translation and editing, discrepancies, omissions, or inaccuracies may exist when compared with the original source.
Where applicable, readers are advised to refer to the original source for the most complete and accurate information. If you identify any errors or believe that any content infringes upon your rights, please contact us at info@2firsts.com, and we will review and address the matter promptly.
